OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Tumoral MGMT content predicts survival in patients with aggressive pituitary tumors and pituitary carcinomas given treatment with temozolomide
Daniel Bengtsson, Henrik Daa Schrøder, Katarina Berinder, et al.
Endocrine (2018) Vol. 62, Iss. 3, pp. 737-739
Closed Access | Times Cited: 23
Daniel Bengtsson, Henrik Daa Schrøder, Katarina Berinder, et al.
Endocrine (2018) Vol. 62, Iss. 3, pp. 737-739
Closed Access | Times Cited: 23
Showing 23 citing articles:
Aggressive Pituitary Tumors and Pituitary Carcinomas: From Pathology to Treatment
Pia Burman, Olivera Casar‐Borota, Luis Gustavo Perez‐Rivas, et al.
The Journal of Clinical Endocrinology & Metabolism (2023) Vol. 108, Iss. 7, pp. 1585-1601
Open Access | Times Cited: 39
Pia Burman, Olivera Casar‐Borota, Luis Gustavo Perez‐Rivas, et al.
The Journal of Clinical Endocrinology & Metabolism (2023) Vol. 108, Iss. 7, pp. 1585-1601
Open Access | Times Cited: 39
Immunotherapy in Corticotroph and Lactotroph Aggressive Tumors and Carcinomas: Two Case Reports and a Review of the Literature
C. Duhamel, Mirela Diana Ilie, Henri Salle, et al.
Journal of Personalized Medicine (2020) Vol. 10, Iss. 3, pp. 88-88
Open Access | Times Cited: 70
C. Duhamel, Mirela Diana Ilie, Henri Salle, et al.
Journal of Personalized Medicine (2020) Vol. 10, Iss. 3, pp. 88-88
Open Access | Times Cited: 70
Dopamine agonist resistant prolactinomas: any alternative medical treatment?
Pedro Souteiro, Niki Karavitaki
Pituitary (2019) Vol. 23, Iss. 1, pp. 27-37
Open Access | Times Cited: 59
Pedro Souteiro, Niki Karavitaki
Pituitary (2019) Vol. 23, Iss. 1, pp. 27-37
Open Access | Times Cited: 59
Giant Prolactinomas
Ilan Shimon
Neuroendocrinology (2018) Vol. 109, Iss. 1, pp. 51-56
Open Access | Times Cited: 51
Ilan Shimon
Neuroendocrinology (2018) Vol. 109, Iss. 1, pp. 51-56
Open Access | Times Cited: 51
Emerging and Novel Treatments for Pituitary Tumors
Mirela Diana Ilie, Hélène Lasolle, Gérald Raverot
Journal of Clinical Medicine (2019) Vol. 8, Iss. 8, pp. 1107-1107
Open Access | Times Cited: 46
Mirela Diana Ilie, Hélène Lasolle, Gérald Raverot
Journal of Clinical Medicine (2019) Vol. 8, Iss. 8, pp. 1107-1107
Open Access | Times Cited: 46
Aggressive corticotroph tumors and carcinomas
Hélène Lasolle, Alexandre Vasiljevic, Emmanuel Jouanneau, et al.
Journal of Neuroendocrinology (2022) Vol. 34, Iss. 8
Open Access | Times Cited: 25
Hélène Lasolle, Alexandre Vasiljevic, Emmanuel Jouanneau, et al.
Journal of Neuroendocrinology (2022) Vol. 34, Iss. 8
Open Access | Times Cited: 25
Aggressive Pituitary Adenomas and Carcinomas
Mirela Diana Ilie, Emmanuel Jouanneau, Gérald Raverot
Endocrinology and Metabolism Clinics of North America (2020) Vol. 49, Iss. 3, pp. 505-515
Open Access | Times Cited: 35
Mirela Diana Ilie, Emmanuel Jouanneau, Gérald Raverot
Endocrinology and Metabolism Clinics of North America (2020) Vol. 49, Iss. 3, pp. 505-515
Open Access | Times Cited: 35
Clinical Efficacy of Temozolomide and Its Predictors in Aggressive Pituitary Tumors and Pituitary Carcinomas: A Systematic Review and Meta-Analysis
Mei Luo, Yiheng Tan, Wenli Chen, et al.
Frontiers in Neurology (2021) Vol. 12
Open Access | Times Cited: 24
Mei Luo, Yiheng Tan, Wenli Chen, et al.
Frontiers in Neurology (2021) Vol. 12
Open Access | Times Cited: 24
Invited Review: Pathology of pituitary neuroendocrine tumours: present status, modern diagnostic approach, controversies and future perspectives from a neuropathological and clinical standpoint
Emilija Manojlović-Gačić, Jens Bollerslev, Olivera Casar‐Borota
Neuropathology and Applied Neurobiology (2019) Vol. 46, Iss. 2, pp. 89-110
Open Access | Times Cited: 27
Emilija Manojlović-Gačić, Jens Bollerslev, Olivera Casar‐Borota
Neuropathology and Applied Neurobiology (2019) Vol. 46, Iss. 2, pp. 89-110
Open Access | Times Cited: 27
Temozolomide therapy for aggressive pituitary tumours – current understanding and future perspectives
Pia Burman, Lydia S. Lamb, Ann McCormack
Reviews in Endocrine and Metabolic Disorders (2020) Vol. 21, Iss. 2, pp. 263-276
Closed Access | Times Cited: 25
Pia Burman, Lydia S. Lamb, Ann McCormack
Reviews in Endocrine and Metabolic Disorders (2020) Vol. 21, Iss. 2, pp. 263-276
Closed Access | Times Cited: 25
Temozolomide Is a Potential Therapeutic Tool for Patients With Metastatic Pheochromocytoma/Paraganglioma—Case Report and Review of the Literature
Anli Tong, Ming Li, Yunying Cui, et al.
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 23
Anli Tong, Ming Li, Yunying Cui, et al.
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 23
Aggressive and Malignant Prolactinomas
Nicoleta Cristina Olarescu, Luis Gustavo Perez‐Rivas, Federico Gatto, et al.
Neuroendocrinology (2019) Vol. 109, Iss. 1, pp. 57-69
Open Access | Times Cited: 22
Nicoleta Cristina Olarescu, Luis Gustavo Perez‐Rivas, Federico Gatto, et al.
Neuroendocrinology (2019) Vol. 109, Iss. 1, pp. 57-69
Open Access | Times Cited: 22
Treatment Options for Gonadotroph Tumors: Current State and Perspectives
Mirela Diana Ilie, Gérald Raverot
The Journal of Clinical Endocrinology & Metabolism (2020) Vol. 105, Iss. 10, pp. e3507-e3518
Open Access | Times Cited: 19
Mirela Diana Ilie, Gérald Raverot
The Journal of Clinical Endocrinology & Metabolism (2020) Vol. 105, Iss. 10, pp. e3507-e3518
Open Access | Times Cited: 19
Aggressive pituitary neuroendocrine tumors: current practices, controversies, and perspectives, on behalf of the EANS skull base section
Sam Ng, Mahmoud Messerer, Julien Engelhardt, et al.
Acta Neurochirurgica (2021) Vol. 163, Iss. 11, pp. 3131-3142
Closed Access | Times Cited: 14
Sam Ng, Mahmoud Messerer, Julien Engelhardt, et al.
Acta Neurochirurgica (2021) Vol. 163, Iss. 11, pp. 3131-3142
Closed Access | Times Cited: 14
New and Emerging Biomarkers in Endocrine Pathology
Thomas Papathomas, Vânia Nosé
Advances in Anatomic Pathology (2019) Vol. 26, Iss. 3, pp. 198-209
Closed Access | Times Cited: 13
Thomas Papathomas, Vânia Nosé
Advances in Anatomic Pathology (2019) Vol. 26, Iss. 3, pp. 198-209
Closed Access | Times Cited: 13
A novel infram deletion in MSH6 gene in glioma: Conversation on MSH6 mutations in brain tumors
Zeinab Deris Zayeri, Maryam Tahmasebi Birgani, Javad Mohammadi‐Asl, et al.
Journal of Cellular Physiology (2018) Vol. 234, Iss. 7, pp. 11092-11102
Closed Access | Times Cited: 10
Zeinab Deris Zayeri, Maryam Tahmasebi Birgani, Javad Mohammadi‐Asl, et al.
Journal of Cellular Physiology (2018) Vol. 234, Iss. 7, pp. 11092-11102
Closed Access | Times Cited: 10
Multimodal therapy in aggressive pituitary tumors
Pedro Iglesias, Rosa Magallón-Botaya, Mercedes Mitjavila, et al.
Endocrinología Diabetes y Nutrición (2019) Vol. 67, Iss. 7, pp. 469-485
Closed Access | Times Cited: 8
Pedro Iglesias, Rosa Magallón-Botaya, Mercedes Mitjavila, et al.
Endocrinología Diabetes y Nutrición (2019) Vol. 67, Iss. 7, pp. 469-485
Closed Access | Times Cited: 8
Knowing when to discontinue Temozolomide therapy in responding aggressive pituitary tumors and carcinomas: a systematic review and Padua (Italy) case series
Marta Padovan, Giulia Cerretti, Mario Caccese, et al.
Expert Review of Endocrinology & Metabolism (2023) Vol. 18, Iss. 2, pp. 181-198
Closed Access | Times Cited: 2
Marta Padovan, Giulia Cerretti, Mario Caccese, et al.
Expert Review of Endocrinology & Metabolism (2023) Vol. 18, Iss. 2, pp. 181-198
Closed Access | Times Cited: 2
Prolactinoma e hiperprolactinemia. Posicionamiento de la SMNE
Ernesto Sosa, Daniel Cuevas‐Ramos, Benito Domínguez, et al.
Revista Mexicana de Endocrinología Metabolismo y Nutrición (2023) Vol. 10, Iss. 91
Open Access | Times Cited: 2
Ernesto Sosa, Daniel Cuevas‐Ramos, Benito Domínguez, et al.
Revista Mexicana de Endocrinología Metabolismo y Nutrición (2023) Vol. 10, Iss. 91
Open Access | Times Cited: 2
Prolactinoma
Philippe Chanson, Dominique Maiter
Pituitary (2022), pp. 495-543
Closed Access | Times Cited: 2
Philippe Chanson, Dominique Maiter
Pituitary (2022), pp. 495-543
Closed Access | Times Cited: 2
Multimodal therapy in aggressive pituitary tumors
Pedro Iglesias, Rosa Magallón-Botaya, Mercedes Mitjavila, et al.
Endocrinología Diabetes y Nutrición (English ed ) (2020) Vol. 67, Iss. 7, pp. 469-485
Closed Access | Times Cited: 2
Pedro Iglesias, Rosa Magallón-Botaya, Mercedes Mitjavila, et al.
Endocrinología Diabetes y Nutrición (English ed ) (2020) Vol. 67, Iss. 7, pp. 469-485
Closed Access | Times Cited: 2
Present and Future of Personalised Medicine for Endocrine Cancers
Cristina L. Ronchi, Barbara Altieri
MDPI eBooks (2022)
Open Access | Times Cited: 1
Cristina L. Ronchi, Barbara Altieri
MDPI eBooks (2022)
Open Access | Times Cited: 1
Non-functional pituitary carcinoma
Haiyong He, Ying Guo, Manting Li, et al.
Nepal Journal of Neuroscience (2021) Vol. 18, Iss. 4, pp. 49-53
Open Access
Haiyong He, Ying Guo, Manting Li, et al.
Nepal Journal of Neuroscience (2021) Vol. 18, Iss. 4, pp. 49-53
Open Access
